Literature DB >> 19955658

CD27 sustains survival of CTLs in virus-infected nonlymphoid tissue in mice by inducing autocrine IL-2 production.

Victor Peperzak1, Yanling Xiao, Elise A M Veraar, Jannie Borst.   

Abstract

Immunity to infections relies on clonal expansion of CD8+ T cells, their maintenance as effector CTLs, and their selection into a memory population. These processes rely on delivery of survival signals to activated CD8+ T cells. We here reveal the mechanism by which costimulatory CD27-CD70 interactions sustain survival of CD8+ effector T cells in infected tissue. By unbiased genome-wide gene expression analysis, we identified the Il2 gene as the most prominent CD27 target gene in murine CD8+ T cells. In vitro, CD27 directed IL-2 expression and promoted clonal expansion of primed CD8+ T cells exclusively by IL-2-dependent survival signaling. In mice intranasally infected with influenza virus, Cd27-/- CD8+ effector T cells displayed reduced IL-2 production, accompanied by impaired accumulation in lymphoid organs and in the lungs, which constitute the tissue effector site. Reconstitution of Cd27-/- CD8+ T cells with the IL2 gene restored their accumulation to wild-type levels in the lungs, but it did not rescue their accumulation in lymphoid organs. Competition experiments showed that the IL-2 produced under the control of CD27 supported effector CD8+ T cell survival in the lungs in an autocrine manner. We conclude that CD27 signaling directs the IL-2 production that is reportedly essential to sustain survival of virus-specific CTLs in nonlymphoid tissue.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19955658      PMCID: PMC2798690          DOI: 10.1172/JCI40178

Source DB:  PubMed          Journal:  J Clin Invest        ISSN: 0021-9738            Impact factor:   14.808


  49 in total

1.  Naïve CTLs require a single brief period of antigenic stimulation for clonal expansion and differentiation.

Authors:  M J van Stipdonk; E E Lemmens; S P Schoenberger
Journal:  Nat Immunol       Date:  2001-05       Impact factor: 25.606

2.  CD28 costimulation mediates T cell expansion via IL-2-independent and IL-2-dependent regulation of cell cycle progression.

Authors:  L J Appleman; A Berezovskaya; I Grass; V A Boussiotis
Journal:  J Immunol       Date:  2000-01-01       Impact factor: 5.422

3.  Broad programming by IL-2 receptor signaling for extended growth to multiple cytokines and functional maturation of antigen-activated T cells.

Authors:  T R Malek; A Yu; P Scibelli; M G Lichtenheld; E K Codias
Journal:  J Immunol       Date:  2001-02-01       Impact factor: 5.422

4.  Essential role for IL-2 in the regulation of antiviral extralymphoid CD8 T cell responses.

Authors:  Warren N D'Souza; Kimberly S Schluns; David Masopust; Leo Lefrançois
Journal:  J Immunol       Date:  2002-06-01       Impact factor: 5.422

Review 5.  Tolerogenic dendritic cells.

Authors:  Ralph M Steinman; Daniel Hawiger; Michel C Nussenzweig
Journal:  Annu Rev Immunol       Date:  2001-12-19       Impact factor: 28.527

6.  Lethal T cell immunodeficiency induced by chronic costimulation via CD27-CD70 interactions.

Authors:  Kiki Tesselaar; Ramon Arens; Gijs M W van Schijndel; Paul A Baars; Martin A van der Valk; Jannie Borst; Marinus H J van Oers; René A W van Lier
Journal:  Nat Immunol       Date:  2002-12-09       Impact factor: 25.606

Review 7.  Retrovirus-mediated gene transfer and expression cloning: powerful tools in functional genomics.

Authors:  Toshio Kitamura; Yuko Koshino; Fumi Shibata; Toshihiko Oki; Hideaki Nakajima; Tetsuya Nosaka; Hidetoshi Kumagai
Journal:  Exp Hematol       Date:  2003-11       Impact factor: 3.084

8.  Constitutive CD27/CD70 interaction induces expansion of effector-type T cells and results in IFNgamma-mediated B cell depletion.

Authors:  R Arens; K Tesselaar; P A Baars; G M van Schijndel; J Hendriks; S T Pals; P Krimpenfort; J Borst; M H van Oers; R A van Lier
Journal:  Immunity       Date:  2001-11       Impact factor: 31.745

Review 9.  Cytokine control of memory T-cell development and survival.

Authors:  Kimberly S Schluns; Leo Lefrançois
Journal:  Nat Rev Immunol       Date:  2003-04       Impact factor: 53.106

10.  CD27 promotes survival of activated T cells and complements CD28 in generation and establishment of the effector T cell pool.

Authors:  Jenny Hendriks; Yanling Xiao; Jannie Borst
Journal:  J Exp Med       Date:  2003-10-27       Impact factor: 14.307

View more
  56 in total

Review 1.  Early events governing memory CD8+ T-cell differentiation.

Authors:  Joshua J Obar; Leo Lefrançois
Journal:  Int Immunol       Date:  2010-05-26       Impact factor: 4.823

Review 2.  Cross-priming in health and disease.

Authors:  Christian Kurts; Bruce W S Robinson; Percy A Knolle
Journal:  Nat Rev Immunol       Date:  2010-06       Impact factor: 53.106

Review 3.  The opposing roles of CD4+ T cells in anti-tumour immunity.

Authors:  Tomasz Ahrends; Jannie Borst
Journal:  Immunology       Date:  2018-04-27       Impact factor: 7.397

4.  Epigenetic modifications induced by Blimp-1 Regulate CD8⁺ T cell memory progression during acute virus infection.

Authors:  Hyun Mu Shin; Varun Kapoor; Tianxia Guan; Susan M Kaech; Raymond M Welsh; Leslie J Berg
Journal:  Immunity       Date:  2013-10-10       Impact factor: 31.745

Review 5.  Searching for "signal 2": costimulation requirements of γδ T cells.

Authors:  Julie C Ribot; Ana debarros; Bruno Silva-Santos
Journal:  Cell Mol Life Sci       Date:  2011-05-04       Impact factor: 9.261

6.  Epitope specificity delimits the functional capabilities of vaccine-induced CD8 T cell populations.

Authors:  Brenna J Hill; Patricia A Darrah; Zachary Ende; David R Ambrozak; Kylie M Quinn; Sam Darko; Emma Gostick; Linda Wooldridge; Hugo A van den Berg; Vanessa Venturi; Martin Larsen; Miles P Davenport; Robert A Seder; David A Price; Daniel C Douek
Journal:  J Immunol       Date:  2014-10-27       Impact factor: 5.422

Review 7.  Stimulating CD27 to quantitatively and qualitatively shape adaptive immunity to cancer.

Authors:  Timothy Nj Bullock
Journal:  Curr Opin Immunol       Date:  2017-03-17       Impact factor: 7.486

Review 8.  Re-adapting T cells for cancer therapy: from mouse models to clinical trials.

Authors:  Ingunn M Stromnes; Thomas M Schmitt; Aude G Chapuis; Sunil R Hingorani; Philip D Greenberg
Journal:  Immunol Rev       Date:  2014-01       Impact factor: 12.988

Review 9.  The genetics of macrophage activation syndrome.

Authors:  Grant S Schulert; Randy Q Cron
Journal:  Genes Immun       Date:  2020-04-15       Impact factor: 2.676

10.  The IL-2 defect in systemic lupus erythematosus disease has an expansive effect on host immunity.

Authors:  Linda A Lieberman; George C Tsokos
Journal:  J Biomed Biotechnol       Date:  2010-06-06
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.